We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Response to Song.
- Authors
Korde, Larissa A; Best, Ana F
- Abstract
Cancer treatments, particularly immunotherapies, are known to affect inflammatory responses, and it is yet unknown how this may affect the disease course of COVID-19 in those receiving active cancer treatment. It is worth noting that patients who had received an allogeneic stem cell transplant or chimeric antigen receptor T-cell therapy at any time in the past were eligible for our study; our intent was to capture a wide range of patients with ongoing immune effects of treatment. In the transplant treatment category, only 13% had received chimeric antigen receptor T-cell therapy, and of those, the majority received treatment treated more than 3 months prior to their diagnosis of COVID-19, making it unlikely that concurrent cytokine release syndrome was present.
- Subjects
SARS-CoV-2; COVID-19; CHIMERIC antigen receptors; CYTOKINE release syndrome
- Publication
JNCI: Journal of the National Cancer Institute, 2023, Vol 115, Issue 6, p768
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djad054